Authors
Ippolitova A.O., Fayzrakhmanov R.R., Shishkin M.M., Karpov G.O., Bosov E.D.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Introduction. A subretinal hemorrhage is defined by the accumulation of blood between the neurosensory retina and the retinal pigment epithelium. It is associated with an acute reduction in visual acuity and leads to the development of irreversible retinal alterations. Over recent decades, surgical management strategies have undergone significant evolution, progressing from mechanical evacuation of the accumulated blood and macular translocation to the incorporation of fibrinolytic agents, pneumatic displacement techniques, and contemporary microinvasive therapeutic approaches. Despite the broad spectrum of available interventions, no universally accepted treatment algorithm has been established. The optimal timing for surgical intervention and the specific indications for individual treatment modalities remain subjects of ongoing debate.
Keywords: subretinal hemorrhage, submacular hemorrhage, age-related macular degeneration, subretinal injection, surgical treatment.
References
1. Fayzrakhmanov RR, Bosov ED, Sukhanova AV. Assessment of morphological and functional results of treatment of patients with subfoveal hemorrhage secondary to AMD. Modern Technologies in Ophthalmology. 2021; 3: 179–184. (In Russ.) doi: 10.25276/2312-4911-2021-3-179-184.
2. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Survey of Ophthalmology. 1997; 42(3): 195–213. doi: 10.1016/s0039-6257(97)00089-1.
3. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. The Lancet Global Health. 2014; 2(2): e106–e116. doi: 10.1016/S2214-109X(13)70145-1.
4. Neroev VV. Russia’s nationwide epidemiological noninvasive study of patients with wet age-related macular degeneration. Russian Ophthalmological Journal. 2011;4(2):4–9. (In Russ.).
5. Hanscom TA, Diddie KR. Early surgical drainage of macular subretinal hemorrhage. Archives of Ophthalmology. 1987; 105(12): 1722–1723. doi: 10.1001/archopht.1987.01060120120037.
6. De Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of AMD. The American Journal of Ophthalmology. 1988; 105(1): 25–29. doi: 10.1016/0002-9394(88)90116-x.
7. Peyman GA, Blinder KJ, Paris CL, et al. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surgery, Lasers and Imaging Retina. 1991; 22(2): 102–108. doi: 10.3928/1542-8877-19910201-12.
8. MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PMG, Milliken AB, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007; 114(3): 561–570. doi: 10.1016/j.ophtha.2006.06.049.
9. Gibran SK, Romano MR, Wong D. Perfluorocarbon liquid assisted large retinal epithelium patching in submacular hemorrhage secondary to age-related macular degeneration Graefe’s Archive for Clinical and Experimental Ophthalmology. 2009; 247: 187–191. doi: 10.1007/s00417-008-0958-5.
10. Van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: Results up to 7 years. The American Journal of Ophthalmology. 2012; 153(1): 120–127. doi: 10.1016/j.ajo. 2011.06.007.
11. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefe’s Archive for Clinical and Experimental Ophthalmology. 1993; 231: 635–641. doi: 10.1007/BF00921957.
12. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. British Journal of Ophthalmology. 2003; 87(5): 615–621. doi: 10.1136/bjo.87.5.615.
13. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007; 114(2): 246–252. doi: 10.1016/j.ophtha.2006.10.045.
14. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1999; 237: 313–325. doi: 10.1007/s004170050239.
15. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. The American Journal of Ophthalmology. 2002; 134(4): 560–565. doi: 10.1016/s0002-9394(02)01641-0.
16. Wolf S, Lappas A, Weinberger AW, Kirchhof B. Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: First results. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1999; 237: 51–57. doi: 10.1007/s004170050194.
17. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999; 106(10): 1900–1907. doi: 10.1016/S0161-6420(99)90399-8.
18. Toth CA, Morse LS, Hjelmeland LM, Landers MB. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Archives of Ophthalmology. 1991; 109(5): 723–729. doi: 10.1001/archopht.1991.01080050139046.
19. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. The American Journal of Ophthalmology. 1994; 118(5): 559–568. doi: 10.1016/s0002-9394(14)76571-7.
20. Peyman GA, Nelson NCJ, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surgery, Lasers and Imaging Retina. 1991; 22(10): 575–582. doi: 10.3928/ 1542-8877-19911001-07.
21. Martel JN, Mahmoud TH. Subretinal pneumatic displacement of subretinal hemorrhage. JAMA Ophthalmology. 2013; 131(12): 1632–1635. doi: 10.1001/jamaophthalmol.2013.5464.
22. Ogata M, Oh H, Nakata A, et al. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator. Scientific Reports. 2022; 12: 22139. doi: 10.1038/s41598-022-26289-6.
23. Abdulaal M, Robertson J, Moore MT, Coney JM. Subretinal pneumatic displacement without tissue plasminogen activator for submacular hemorrhage: One-year outcomes. Investigative Ophthalmology and Visual Science. 2021; 62(8): 3663. Available from: https://clck.su/LOMwM. Аccessed 1 August 2026.
24. He X, Cao W, Wang Z, et al. Efficacy evaluation of tissue plasminogen activator with anti-vascular endothelial growth factor drugs for submacular hemorrhage treatment: A meta-analysis. Journal of Clinical Medicine. 2023; 12(3): 1035. https://doi.org/10.3390/jcm12031035.
25. Ovchinnikova AD, Mironov AV, Dulgieru TO. The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection. Ophthalmosurgery. 2020; 4: 43–49. (In Russ.) doi: 10.25276/0235-4160-2020-4-43-49.
26. Bosov ED, Fayzrakhmanov RR, Bogdanova VA, Vaganova EE. Minimally invasive surgical treatment for organized submacular hemorrhage. Clinical Cases in Ophthalmology 2023; 1: 30–34. (In Russ.) doi: 10.25276/2949-4494-2023-1-30-34.
27. Fayzrakhmanov RR, Bosov ED, Shishkin MM, Sukhanova AV. Changes of retinal morphofunctional parameters after submacular hemorrhage surgery. Saratov Journal of Medical Scientific Research. 2021; 17(2): 388–392. (In Russ.)
28. Bosov ED, Fayzrakhmanov RR, Karpov GO, Kalinin ME. Postoperative multimodal analysis results of surgical treatment of submacular hemorrhages. Modern Technologies in Ophthalmology. 2022; 4: 9–15. (In Russ.) doi: 10.25276/2312-4911-2022-4-9-15.


